Physician profile
Robert C Schutt
NPI 1144454349
$2,391.40
in general payments reported to CMS, 2019-2025
25 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $97.84 · 2021: $81.49 · 2022: $586 · 2023: $359 · 2024: $732 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,278.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $660.49 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $550.05 | 2021-2023 | Impella |
| Boston Scientific Corporation | $260.77 | 2019-2025 | Watchman Flx |
| Penumbra, INC. | $133.98 | 2024-2025 | Indigo System, Penumbra System |
| Cvrx, INC. | $133.02 | 2022 | |
| Angiodynamics, INC. | $119.39 | 2024-2025 | Alphavac, Auryon Laser System 100-120 Vac |
| Novartis Pharmaceuticals Corporation | $75.14 | 2019-2024 | |
| Amgen INC. | $57.01 | 2019-2024 | Repatha |
| Stryker Corporation | $52.05 | 2025 | Artix Mt, Flowtriever |
| Janssen Pharmaceuticals, INC | $48.18 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $40.94 | 2019-2020 | |
| Reflow Medical INC | $38.94 | 2024 | |
| Abbott Laboratories | $28.26 | 2019-2023 | Proclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.90 | 2020 | |
| Siemens Medical Solutions USA, INC. | $19.53 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $18.67 | 2019 | |
| Biotronik INC. | $18.57 | 2020 | |
| Esperion Therapeutics, INC. | $18.46 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.70 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $14.29 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.08 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.02 | 2020 | |
| Pfizer INC. | $13.74 | 2019 | |
| Baylis Medical Company INC | $13.15 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Schutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.